Application of Nanoparticles on Diagnosis and Therapy in Gliomas
Open Access
- 18 April 2013
- journal article
- review article
- Published by Hindawi Limited in BioMed Research International
- Vol. 2013, 1-20
- https://doi.org/10.1155/2013/351031
Abstract
Glioblastoma multiforme (GBM) is one of the most deadly diseases that affect humans, and it is characterized by high resistance to chemotherapy and radiotherapy. Its median survival is only fourteen months, and this dramatic prognosis has stilled without changes during the last two decades; consequently GBM remains as an unsolved clinical problem. Therefore, alternative diagnostic and therapeutic approaches are needed for gliomas. Nanoparticles represent an innovative tool in research and therapies in GBM due to their capacity of self-assembly, small size, increased stability, biocompatibility, tumor-specific targeting using antibodies or ligands, encapsulation and delivery of antineoplastic drugs, and increasing the contact surface between cells and nanomaterials. The active targeting of nanoparticles through conjugation with cell surface markers could enhance the efficacy of nanoparticles for delivering several agents into the tumoral area while significantly reducing toxicity in living systems. Nanoparticles can exploit some biological pathways to achieve specific delivery to cellular and intracellular targets, including transport across the blood-brain barrier, which many anticancer drugs cannot bypass. This review addresses the advancements of nanoparticles in drug delivery, imaging, diagnosis, and therapy in gliomas. The mechanisms of action, potential effects, and therapeutic results of these systems and their future applications in GBM are discussed.This publication has 160 references indexed in Scilit:
- Phase 2 study of carboplatin, irinotecan, and bevacizumab for recurrent glioblastoma after progression on bevacizumab therapyCancer, 2011
- Chlorotoxin bound magnetic nanovector tailored for cancer cell targeting, imaging, and siRNA deliveryBiomaterials, 2010
- Gadolinium‐Conjugated Dendrimer Nanoclusters as a Tumor‐Targeted T1 Magnetic Resonance Imaging Contrast AgentAngewandte Chemie, 2009
- Magnetic nanoparticles for theragnosticsAdvanced Drug Delivery Reviews, 2009
- Glioblastoma targeting via integrins is concentration dependentBiotechnology & Bioengineering, 2009
- Self-refocused spatial-spectral pulse for positive contrast imaging of cells labeled with SPIO nanoparticlesMagnetic Resonance in Medicine, 2009
- Combination of active specific immunotherapy or adoptive antibody or lymphocyte immunotherapy with chemotherapy in the treatment of cancerCancer Immunology, Immunotherapy, 2008
- Bioconjugated quantum dots for in vivo molecular and cellular imagingAdvanced Drug Delivery Reviews, 2008
- Multifunctional magnetic nanoparticles for targeted imaging and therapyAdvanced Drug Delivery Reviews, 2008
- Iron oxide nanoparticles as a drug delivery vehicle for MRI monitored magnetic targeting of brain tumorsBiomaterials, 2008